Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-07 06:44:37 - browse：919

FDA-Blood Sugar Monitor — The FDA has approved a device from Abbott that continuously monitors diabetics’ blood sugar levels without requiring backup finger prick tests. Abbott Laboratories via AP

U.S. regulators have approved the first continuous blood sugar monitor for diabetics that doesn’t need backup finger prick tests.

Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor.

The pain of finger sticks and the cost of testing supplies discourage many people from keeping close tabs on their blood sugar, which is needed to manage insulin use and adjust what they eat.

Abbott’s new FreeStyle Libre Flash Glucose Monitoring System, approved Wednesday by the Food and Drug Administration, uses a small sensor attached to the upper arm. Patients wave a reader device over it to see the current blood sugar level and changes over the past eight hours.

Most of the 30 million Americans with diabetes use standard glucose meters, which require multiple finger pricks each day and only show current sugar level. More-accurate continuous glucose monitoring devices are used by about 345,000 Americans.

Newsletters

Sign up for Morning Rounds

Your daily dose of news in health and medicine.

Please enter a valid email address. Privacy Policy

But most don’t do the finger pricks to calibrate them and may get inaccurate readings, said Dr. Timothy Bailey, who helped test FreeStyle Libre.

“We’re able to lower blood sugar safely” with this technology, said Bailey, director of the Advanced Metabolic Care and Research Institute in California. He receives consulting fees from various diabetes device makers.

Too-high blood sugar levels can damage organs and lead to heart attacks, strokes, blindness and amputations. Very low blood sugar can cause seizures, confusion and loss of consciousness.

Abbott’s device was approved for adults with type 1 or type 2 diabetes and should be available in pharmacies within months. The company, based near Chicago, did not disclose the price of the reader or the sensors.

Abbott’s system can’t be used with an insulin pump, a device worn against the skin that allows users to inject insulin as needed, but the company is planning improvements to eventually enable that.

Rival Medtronic this spring launched a device in which the insulin pump automatically responds to blood sugar changes recorded by the sensor and either withholds or injects insulin as needed.

— Linda A. Johnson

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Listen: PBM conflicts, RSV vaccines, & the future of flu season

knowledge

WSS

Dairy farmers resist CDC push for PPE against bird flu virus

Listen: Biogen's messy board & Laronde's data problem

Australia's humpback populations rebound raising hopes of marine scientists

Community addresses injustice for Long Island mothers

Making AI in medicine accessible to smaller, and rural hospitals

PhRMA sues HHS over Medicare drug price negotiation

explore

Wikipedia

Sign up for Morning Rounds

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Sanofi strikes deal with Novavax, boosting the vaccine maker

In Memoriam: Notable people who died in 2023

Grail is spending more than ever lobbying Congress

The cancer drug shortage isn’t new — and neither are the solutions

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Medical leaders decry Supreme Court decision on affirmative action

What nurses really want: sufficient staffing for patient care

At least 13 dead in Texas as scorching temps continue

Shionogi licenses Pompe disease therapy from Maze Therapeutics

focus

How to improve immunocompromised access to mAb treatments

Telehealth startups turn to complex chronic diseases

Readout LOUD podcast: What to know about H5N1 bird flu

First recipient of genetically engineered pig kidney has died

Brain worms: The science behind RFK Jr.'s parasitic infection

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

focus

leisure time

knowledge

knowledge